In this study it was aimed to investigate the relationship between myogenic temporomandibular disorders (mTMD) and depression and quality of life in non-dialysis chronic kidney disease (NDCKD).
MethodsThis study included 214 with NDCKD patients. The diagnosis of mTMD was based on the Fonseca Anamnestic Index (FAI). Depression was assessed using the Beck Depression Inventory (BDI). Health-related quality of life (HRQOL) was determined using the Short Form-36 (SF-36).
Results40.6% of 214 patients were diagnosed with mTMD. mTMD prevalence in stage-3, -4, and -5 NDCKD patients were 33.6%, 46.8%, and 57.1% respectively. 32.2% of the patients were diagnosed with depression. The prevalence of depression in NDCKD stage-3, -4 and 5 was 27.8%, 32.8% and 50%, respectively. Depression was detected in 42.5% of the patients presenting with mTMD and 25.1% with no TMD (p=0.004). mTMD severity was positively associated with the BDI score and C-reactive protein, and negatively with albumin, the Physical Component Summary Score, and Mental Component Summary scores of SF-36. SF-36 score showed a statistically significant negative correlation with FAI and BDI scores (p <0.05).
ConclusionMyogenic TMD is very common among patients with NDCKD patients and is related to depression and HRQOL.